Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 7, Pages 759-769
Publisher
Informa Healthcare
Online
2014-05-03
DOI
10.1517/14728222.2014.914173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
- (2013) V. Nair et al. CARCINOGENESIS
- Triptolide-induced Cell Death in Pancreatic Cancer Is Mediated byO-GlcNAc Modification of Transcription Factor Sp1
- (2013) Sulagna Banerjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Cannabinoid WIN 55,212-2 Decreases Specificity Protein Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells
- (2013) Sandeep Sreevalsan et al. MOLECULAR CANCER THERAPEUTICS
- The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis
- (2013) Giuliana D. Noratto et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Aspirin and cancer risk: a quantitative review to 2011
- (2012) C. Bosetti et al. ANNALS OF ONCOLOGY
- Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs
- (2012) Stephen H. Safe et al. Anti-Cancer Agents in Medicinal Chemistry
- Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells
- (2012) Gayathri Chadalapaka et al. CARCINOGENESIS
- Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors
- (2012) Gayathri Chadalapaka et al. INTERNATIONAL JOURNAL OF CANCER
- The Chinese Herb Isolate Isorhapontigenin Induces Apoptosis in Human Cancer Cells by Down-regulating Overexpression of Antiapoptotic Protein XIAP
- (2012) Yong Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer
- (2012) Feng Wang et al. JOURNAL OF PATHOLOGY
- Effect of Tolfenamic Acid on Canine Cancer Cell Proliferation, Specificity Protein (Sp) Transcription Factors, and Sp-Regulated Proteins in Canine Osteosarcoma, Mammary Carcinoma, and Melanoma Cells
- (2012) H. Wilson et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer
- (2012) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
- (2012) K. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a:ZBTB10
- (2012) Susanne U. Mertens-Talcott et al. MOLECULAR CARCINOGENESIS
- Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax
- (2012) H-J Yu et al. ORAL DISEASES
- Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence
- (2012) Roble G. Bedolla et al. PLoS One
- Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors
- (2012) Satya Pathi et al. PLoS One
- Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer
- (2012) Umesh T. Sankpal et al. PROSTATE
- Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis
- (2011) Y. Gao et al. CANCER RESEARCH
- Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
- (2011) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Induction of Cross-Linking and Silencing of Sp1 by Transglutaminase during Liver Injury in ASH and NASH via Different ER Stress Pathways
- (2011) Soichi Kojima et al. DIGESTIVE DISEASES
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome
- (2011) Hongyu Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats
- (2011) Pius Maliakal et al. INVESTIGATIONAL NEW DRUGS
- Interplay of Posttranslational Modifications in Sp1 Mediates Sp1 Stability during Cell Cycle Progression
- (2011) Yi-Ting Wang et al. JOURNAL OF MOLECULAR BIOLOGY
- Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins
- (2011) Sudhakar Chintharlapalli et al. MOLECULAR CARCINOGENESIS
- Sp1 expression regulates lung tumor progression
- (2011) T-I Hsu et al. ONCOGENE
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
- (2010) Subash C. Gupta et al. CANCER AND METASTASIS REVIEWS
- Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity
- (2010) Z. Jia et al. CANCER RESEARCH
- Overexpression of Transcription Factor Sp2 Inhibits Epidermal Differentiation and Increases Susceptibility to Wound- and Carcinogen-Induced Tumorigenesis
- (2010) T.-H. Kim et al. CANCER RESEARCH
- Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
- (2010) Indira Jutooru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
- (2010) Ling-Min Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- GT-094, a NO-NSAID, Inhibits Colon Cancer Cell Growth by Activation of a Reactive Oxygen Species-MicroRNA-27a: ZBTB10-Specificity Protein Pathway
- (2010) S. S. Pathi et al. MOLECULAR CANCER RESEARCH
- Drugs that Target Specificity Proteins Downregulate Epidermal Growth Factor Receptor in Bladder Cancer Cells
- (2010) Gayathri Chadalapaka et al. MOLECULAR CANCER RESEARCH
- Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a
- (2010) I. Jutooru et al. MOLECULAR PHARMACOLOGY
- Specificity Protein 2 (Sp2) Is Essential for Mouse Development and Autonomous Proliferation of Mouse Embryonic Fibroblasts
- (2010) Frank Baur et al. PLoS One
- -Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis
- (2009) P.-H. Huang et al. CARCINOGENESIS
- Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
- (2009) S. Papineni et al. CARCINOGENESIS
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Targeting mitochondrial apoptosis by betulinic acid in human cancers
- (2009) Simone Fulda et al. DRUG DISCOVERY TODAY
- Role of Transglutaminase 2 in Liver Injury via Cross-linking and Silencing of Transcription Factor Sp1
- (2009) Hideki Tatsukawa et al. GASTROENTEROLOGY
- Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate in colon cancer cells
- (2009) Sudhakar Chintharlapalli et al. INTERNATIONAL JOURNAL OF CANCER
- Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice
- (2009) Jimmie Colon et al. INVESTIGATIONAL NEW DRUGS
- Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression
- (2009) S. Konduri et al. MOLECULAR CANCER THERAPEUTICS
- Thiazolidinediones Mimic Glucose Starvation in Facilitating Sp1 Degradation through the Up-Regulation of -Transducin Repeat-Containing Protein
- (2009) S. Wei et al. MOLECULAR PHARMACOLOGY
- Dual Role of Sp3 Transcription Factor as an Inducer of Apoptosis and a Marker of Tumour Aggressiveness
- (2009) Khadija Essafi-Benkhadir et al. PLoS One
- Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genes
- (2008) Inken Wierstra BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sp1 transcription factor as a target for anthracyclines: Effects on gene transcription
- (2008) Sylvia Mansilla et al. BIOCHIMIE
- Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma
- (2008) N. Y. Jiang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- The development of several organs and appendages is impaired in mice lacking Sp6
- (2008) Valérie Hertveldt et al. DEVELOPMENTAL DYNAMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started